-
The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.
J Psychiatr Res. 1999 May-Jun;33(3):181-214
PMID: 10367986
-
The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders.
Biol Psychiatry. 1999 Dec 1;46(11):1509-22
PMID: 10599479
-
Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
Neuropsychopharmacology. 2000 Feb;22(2):148-62
PMID: 10649828
-
The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain.
Eur J Pharmacol. 2000 Jan 17;387(3):279-86
PMID: 10650173
-
Gender differences in depression and antidepressant pharmacokinetics and adverse events.
Ann Pharmacother. 2000 Jan;34(1):80-8
PMID: 10669189
-
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.
Nat Genet. 2000 Apr;24(4):403-9
PMID: 10742107
-
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
Nat Genet. 2000 Apr;24(4):410-4
PMID: 10742108
-
Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.
Nat Genet. 2000 Apr;24(4):415-9
PMID: 10742109
-
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6079-84
PMID: 10823952
-
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.
J Psychiatr Res. 2000 May-Jun;34(3):171-81
PMID: 10867111
-
Sex differences and the HPA axis: implications for psychiatric disease.
J Gend Specif Med. 1998 Sep;1(1):21-7
PMID: 11279849
-
Gender differences in the genetic epidemiology of major depression.
J Gend Specif Med. 1998 Oct-Nov;1(2):28-31
PMID: 11281009
-
Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.
J Neurosci. 2001 Apr 15;21(8):2833-41
PMID: 11306635
-
The role of functional neuroimaging in the neuropsychology of depression.
J Clin Exp Neuropsychol. 2001 Feb;23(1):121-36
PMID: 11320448
-
Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus.
J Comp Neurol. 2001 Jul 9;435(4):450-63
PMID: 11406825
-
Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.
Neuroscience. 2001;104(3):643-52
PMID: 11440798
-
Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.
J Neurosci. 2002 Jan 1;22(1):193-9
PMID: 11756502
-
Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression.
Curr Opin Pharmacol. 2002 Feb;2(1):23-33
PMID: 11786305
-
Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice.
Neuroscience. 2002;109(2):253-66
PMID: 11801362
-
The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress.
J Neurosci. 2002 Feb 1;22(3):1020-6
PMID: 11826130
-
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.
J Pharmacol Exp Ther. 2002 Apr;301(1):333-45
PMID: 11907191
-
Neurobiology of depression.
Neuron. 2002 Mar 28;34(1):13-25
PMID: 11931738
-
Assessing antidepressant activity in rodents: recent developments and future needs.
Trends Pharmacol Sci. 2002 May;23(5):238-45
PMID: 12008002
-
Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide.
Brain Res. 2002 Jul 5;943(1):142-50
PMID: 12088848
-
Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats.
Brain Res. 1992 Aug 7;587(2):263-8
PMID: 1326376
-
Corticotropin-releasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input.
Neuroscience. 1992;48(3):689-705
PMID: 1376457
-
New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor.
Neuropsychopharmacology. 1992 Feb;6(2):69-75
PMID: 1610487
-
Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system.
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8382-6
PMID: 1681536
-
Corticotropin-releasing factor: putative neurotransmitter in the noradrenergic nucleus locus ceruleus.
Psychopharmacol Bull. 1989;25(3):306-11
PMID: 2576315
-
The role of corticotropin-releasing factor in the pathogenesis of major depression.
Pharmacopsychiatry. 1988 Mar;21(2):76-82
PMID: 3293091
-
Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.
Science. 1981 Sep 18;213(4514):1394-7
PMID: 6267699
-
Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression.
J Neurosci. 1995 Oct;15(10):6340-50
PMID: 7472399
-
Corticotropin-releasing factor neurotransmission in locus coeruleus: a possible site of antidepressant action.
Brain Res Bull. 1994;35(5-6):581-7
PMID: 7859115
-
Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
J Neurosci. 1994 May;14(5 Pt 1):2579-84
PMID: 8182429
-
Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
J Pharmacol Exp Ther. 1994 Jan;268(1):359-65
PMID: 8301577
-
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
Endocrinology. 1996 Dec;137(12):5747-50
PMID: 8940412
-
Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.
J Pharmacol Exp Ther. 1997 Apr;281(1):163-72
PMID: 9103494
-
Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids.
Brain Res. 1997 May 9;756(1-2):114-24
PMID: 9187321
-
Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression.
Exp Clin Psychopharmacol. 1997 May;5(2):107-12
PMID: 9234045
-
Gender differences in depression: implications for treatment.
J Clin Psychiatry. 1997;58 Suppl 15:12-8
PMID: 9427872
-
Effects of corticotropin-releasing factor on brain serotonergic activity.
Neuropsychopharmacology. 1998 Jun;18(6):492-502
PMID: 9571657
-
The forced swimming test as a model for core and component behavioral effects of antidepressant drugs.
Behav Pharmacol. 1997 Nov;8(6-7):523-32
PMID: 9832966
-
The role of corticotropin-releasing factor in depression and anxiety disorders.
J Endocrinol. 1999 Jan;160(1):1-12
PMID: 9854171